Anzeige
Mehr »
Login
Mittwoch, 17.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Ausbruch – startet jetzt die massive FDA-Rallye?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
13:46Alvotech and Teva gain FDA approval of Selarsdi for psoriasis
13:46Johnson & Johnson reports net earnings of $5.3bn in Q1 2024
11:46TetraScience and Google Cloud link for AI-driven drug developments
11:46Medincell and AbbVie make injectable therapy development deal
DiRisk adjusted net present value: What is the current valuation of Novo Nordisk's NN-9931?
DiRisk adjusted net present value: What is the current valuation of Eli Lilly and Co's LY-3972406?
DiRisk adjusted net present value: What is the current valuation of Pfizer's PF-07275315?
DiRisk adjusted net present value: What is the current valuation of Enliven Therapeutics's ELVN-002?
DiRisk adjusted net present value: What is the current valuation of AstraZeneca's AZD-9574?
DiRisk adjusted net present value: What is the current valuation of Novartis's XXB-750?
DiRisk adjusted net present value: What is the current valuation of Novo Nordisk's NNC0519-0130?
DiRisk adjusted net present value: What is the current valuation of AstraZeneca's Sabestomig?
DiJardiance and Ofev propel Boehringer's human pharma sales
DiAcorda loses Nasdaq listing to cap biotech's end
DiHarnessing artificial intelligence and digital technologies across the biopharma value chain
DiTwo major breakthroughs in Fragile X Syndrome treatments
DiLeading API biologics (cell, gene, vaccine and virus) companies in contract manufacturing
DiPharmaceutical testing equipment, analysis, and measurement companies for the pharmaceutical industry
DiQureight secures Series A funding to accelerate drug development
DiFDA halts Neumora's schizophrenia drug trial over convulsions in rabbits
DiFDA grants orphan drug status to NovelMed's PNH treatment
DiIndia sees insignificant revision to price ceiling in 2024
DiNorgine seeks approval for high-risk neuroblastoma treatment
DiSanofi signs mRNA vaccine development deal with IDT Australia
MoMarinus fails to meet early stopping criteria for status epilepticus trial